← Back to directory

Gilles Montalescot

Researcher Next ID · RN-024963

Researcher · Medicine

Inserm

Paris, Netherlands

Not currently recruitingFunding unknown
Works count
1,125
Citation count
81,087
H-index
118
i10-index
489

Research interests

Medicine
Acute Myocardial Infarction Research
Antiplatelet Therapy and Cardiovascular Diseases
Coronary Interventions and Diagnostics
Atrial Fibrillation Management and Outcomes
Venous Thromboembolism Diagnosis and Management

Publications

  • Statin therapy is associated with lower prevalence of gut microbiota dysbiosis

    Nature · 2020 · https://doi.org/10.1038/s41586-020-2269-x

  • 2018 ESC/EACTS Guidelines on myocardial revascularization

    European Heart Journal · 2018 · https://doi.org/10.1093/eurheartj/ehy394

  • Evacetrapib and Cardiovascular Outcomes in High-Risk Vascular Disease

    New England Journal of Medicine · 2017 · https://doi.org/10.1056/nejmoa1609581

  • 2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS

    European Heart Journal · 2017 · https://doi.org/10.1093/eurheartj/ehx419

  • PCI Strategies in Patients with Acute Myocardial Infarction and Cardiogenic Shock

    New England Journal of Medicine · 2017 · https://doi.org/10.1056/nejmoa1710261

  • 2014 ESC/EACTS Guidelines on myocardial revascularization

    European Journal of Cardio-Thoracic Surgery · 2014 · https://doi.org/10.1093/ejcts/ezu366

  • Prehospital Ticagrelor in ST-Segment Elevation Myocardial Infarction

    New England Journal of Medicine · 2014 · 10.1056/nejmoa1407024

  • Pretreatment with Prasugrel in Non–ST-Segment Elevation Acute Coronary Syndromes

    New England Journal of Medicine · 2013 · 10.1056/nejmoa1308075

  • Bedside Monitoring to Adjust Antiplatelet Therapy for Coronary Stenting

    New England Journal of Medicine · 2012 · 10.1056/nejmoa1209979

  • Thrombin-Receptor Antagonist Vorapaxar in Acute Coronary Syndromes

    New England Journal of Medicine · 2011 · 10.1056/nejmoa1109719

  • Double-dose versus standard-dose clopidogrel and high-dose versus low-dose aspirin in individuals undergoing percutaneous coronary intervention for acute coronary syndromes (CURRENT-OASIS 7): a randomised factorial trial

    The Lancet · 2010 · 10.1016/s0140-6736(10)61088-4

  • Reduced-Function CYP2C19 Genotype and Risk of Adverse Clinical Outcomes Among Patients Treated With Clopidogrel Predominantly for PCI

    JAMA · 2010 · 10.1001/jama.2010.1543

  • Consensus and Future Directions on the Definition of High On-Treatment Platelet Reactivity to Adenosine Diphosphate

    Journal of the American College of Cardiology · 2010 · 10.1016/j.jacc.2010.04.047

  • Platelet Inhibition with Cangrelor in Patients Undergoing PCI

    New England Journal of Medicine · 2009 · 10.1056/nejmoa0908628

  • Prasugrel compared with clopidogrel in patients undergoing percutaneous coronary intervention for ST-elevation myocardial infarction (TRITON-TIMI 38): double-blind, randomised controlled trial

    The Lancet · 2009 · 10.1016/s0140-6736(09)60441-4

  • Intravenous Platelet Blockade with Cangrelor during PCI

    New England Journal of Medicine · 2009 · 10.1056/nejmoa0908629

  • Cytochrome P450 2C19 polymorphism in young patients treated with clopidogrel after myocardial infarction: a cohort study

    The Lancet · 2008 · 10.1016/s0140-6736(08)61845-0

  • Facilitated PCI in Patients with ST-Elevation Myocardial Infarction

    New England Journal of Medicine · 2008 · 10.1056/nejmoa0706816

  • Prasugrel versus Clopidogrel in Patients with Acute Coronary Syndromes

    New England Journal of Medicine · 2007 · https://doi.org/10.1056/nejmoa0706482

  • Prasugrel Compared With High Loading- and Maintenance-Dose Clopidogrel in Patients With Planned Percutaneous Coronary Intervention

    Circulation · 2007 · 10.1161/circulationaha.107.740324

  • Patients With Prior Myocardial Infarction, Stroke, or Symptomatic Peripheral Arterial Disease in the CHARISMA Trial

    Journal of the American College of Cardiology · 2007 · 10.1016/j.jacc.2007.03.025

  • Clopidogrel and Aspirin versus Aspirin Alone for the Prevention of Atherothrombotic Events

    New England Journal of Medicine · 2006 · https://doi.org/10.1056/nejmoa060989

  • Addition of Clopidogrel to Aspirin and Fibrinolytic Therapy for Myocardial Infarction with ST-Segment Elevation

    New England Journal of Medicine · 2005 · 10.1056/nejmoa050522

  • Impact of age on management and outcome of acute coronary syndrome: Observations from the global registry of acute coronary events (GRACE)

    American Heart Journal · 2005 · 10.1016/j.ahj.2004.06.003

  • Platelet Glycoprotein IIb/IIIa Inhibition with Coronary Stenting for Acute Myocardial Infarction

    New England Journal of Medicine · 2001 · 10.1056/nejm200106213442503

Current projects

    No projects listed.